Letter: Proton Pump Inhibitors and the Risk of Hepatocellular Carcinoma

Alimentary Pharmacology and Therapeutics - United Kingdom
doi 10.1111/apt.14970
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Letter: Cohort Study Examining the Association Between Proton Pump Inhibitors Therapy and Risk of Hepatocellular Carcinoma in Taiwan-Authors’ Reply

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2018English

Letter: Cohort Study Examining the Association Between Proton Pump Inhibitor Therapy and Risk of Hepatocellular Carcinoma in Taiwan

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2018English

Letter: Proton Pump Inhibitor Use and Risk of Fracture

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2018English

Letter: Proton Pump Inhibitors and Prognosis of Cirrhosis - Searching for the Balance Point

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2016English

Use of Proton Pump Inhibitors and Subsequent Risk of Celiac Disease

Digestive and Liver Disease
HepatologyGastroenterology
2014English

Proton Pump Inhibitors and Gastric Neoplasia

Gut
Gastroenterology
2006English

Community-Acquired Pneumonia and Proton Pump Inhibitors

Journal of General Internal Medicine
Internal Medicine
2013English

Interaction Between Clopidogrel and Proton Pump Inhibitors

CMAJ
Medicine
2009English

Letter: The Association Between the Use of Different Proton Pump Inhibitors and Microscopic Colitis Should Be Re-Evaluated

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy